0001190725-17-000027.txt : 20170130
0001190725-17-000027.hdr.sgml : 20170130
20170130180749
ACCESSION NUMBER: 0001190725-17-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170126
FILED AS OF DATE: 20170130
DATE AS OF CHANGE: 20170130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHEN ISAN
CENTRAL INDEX KEY: 0001586218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 17558757
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS, INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-01-26
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001586218
CHEN ISAN
C/O MIRATI THERAPEUTICS, INC.
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
0
1
0
0
Sr. VP, Chief Medical
Common Stock
18798
D
Option Grant (Right to Buy)
5.4
2017-01-26
4
A
0
50000
0
A
2027-01-25
Common Stock
50000
50000
D
Includes 685 shares acquired under the ESPP on 5/31/16.
1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
/s/ Jamie A. Donadio, Attorney-in-Fact
2017-01-30